Trade Mark Journal No.2026/033 14 August 2026

UK00004401191 11 June 2026 (5)

BYXLENVO

International priority date claimed: 18 December 2025 (Ireland) (2025/03239)

Class 5: Pharmaceutical preparations for the treatment of viral infection, HIV infection, and autoimmune diseases and disorders.

Gilead Sciences Ireland UC

Representative: Aneta Stawska